• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用(125)I-低密度脂蛋白、(125)I-氧化低密度脂蛋白、(125)I-高密度脂蛋白和(125)I-牛血清白蛋白对主动脉粥样硬化病变进行成像。

Imaging of aortic atherosclerotic lesions by (125)I-LDL, (125)I-oxidized-LDL, (125)I-HDL and (125)I-BSA.

作者信息

Shaish A, Keren G, Chouraqui P, Levkovitz H, Harats D

机构信息

Institute of Lipid and Atherosclerosis Research, Tel-Hashomer, Israel.

出版信息

Pathobiology. 2001;69(4):225-9. doi: 10.1159/000055947.

DOI:10.1159/000055947
PMID:12007282
Abstract

OBJECTIVE

The aim of the present study was to compare the accumulation of (125)I-labeled low-density lipoproteins (LDL), oxidized LDL (oxLDL), HDL and BSA in advanced atherosclerotic lesions of apoE-deficient mice.

METHODS

(125)I-lipoproteins or (125)I-BSA were injected into the tail vein of apoE-deficient mice. Blood clearance of (125)I-lipoproteins and (125)I-BSA and their accumulation in atherosclerotic lesions were assayed.

RESULTS

Blood clearance of (125)I-LDL and (125)I-HDL was moderate, and approximately 30% of the injected lipoproteins were present in plasma 24 h following injection. oxLDL was removed much faster from plasma, and less than 10% of (125)I-oxLDL was present in the circulation 30 min after (125)I-oxLDL injection. The clearance of (125)I-BSA from the circulation was slower than the lipoprotein clearance. The highest accumulation of LDL, oxLDL, HDL and BSA was detected in atherosclerotic lesions in the aortic arch and abdominal aorta, while lower accumulation was detected in the less atherosclerotic descending thoracic aorta.

CONCLUSION

Our findings demonstrate that both (125)I-HDL and (125)I-BSA as well as (125)I-LDL are accumulated in atherosclerotic plaques and that they can be used for the detection of atherosclerotic lesions.

摘要

目的

本研究旨在比较载脂蛋白E缺乏小鼠晚期动脉粥样硬化病变中¹²⁵I标记的低密度脂蛋白(LDL)、氧化型LDL(oxLDL)、高密度脂蛋白(HDL)和牛血清白蛋白(BSA)的蓄积情况。

方法

将¹²⁵I标记的脂蛋白或¹²⁵I标记的BSA注入载脂蛋白E缺乏小鼠的尾静脉。检测¹²⁵I标记的脂蛋白和¹²⁵I标记的BSA的血液清除率及其在动脉粥样硬化病变中的蓄积情况。

结果

¹²⁵I-LDL和¹²⁵I-HDL的血液清除率适中,注射后24小时约30%的注入脂蛋白存在于血浆中。oxLDL从血浆中清除得更快,¹²⁵I-oxLDL注射后30分钟,循环中¹²⁵I-oxLDL的含量不到10%。¹²⁵I-BSA从循环中的清除比脂蛋白清除慢。在主动脉弓和腹主动脉的动脉粥样硬化病变中检测到LDL、oxLDL、HDL和BSA的最高蓄积,而在动脉粥样硬化程度较轻的胸降主动脉中检测到的蓄积较低。

结论

我们的研究结果表明,¹²⁵I-HDL、¹²⁵I-BSA以及¹²⁵I-LDL都在动脉粥样硬化斑块中蓄积,并且它们可用于检测动脉粥样硬化病变。

相似文献

1
Imaging of aortic atherosclerotic lesions by (125)I-LDL, (125)I-oxidized-LDL, (125)I-HDL and (125)I-BSA.利用(125)I-低密度脂蛋白、(125)I-氧化低密度脂蛋白、(125)I-高密度脂蛋白和(125)I-牛血清白蛋白对主动脉粥样硬化病变进行成像。
Pathobiology. 2001;69(4):225-9. doi: 10.1159/000055947.
2
Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin.
Coron Artery Dis. 1994 Aug;5(8):695-705. doi: 10.1097/00019501-199408000-00008.
3
Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated.动脉粥样硬化载脂蛋白E缺陷转基因小鼠及人类体内受损的低密度脂蛋白发生了氧化和聚集。
Biochem Biophys Res Commun. 1995 Nov 13;216(2):501-13. doi: 10.1006/bbrc.1995.2651.
4
Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.腹腔内注射比静脉内注射更能提高载脂蛋白 E 基因敲除小鼠动脉粥样硬化斑块对纳米颗粒标记的高密度脂蛋白的摄取:一项多模态成像研究。
Circ Cardiovasc Imaging. 2014 Mar;7(2):303-11. doi: 10.1161/CIRCIMAGING.113.000607. Epub 2013 Dec 19.
5
Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.在低密度脂蛋白受体缺陷小鼠中,循环抗氧化型低密度脂蛋白自身抗体与氧化型低密度脂蛋白在动脉中的蓄积和消耗相关。
Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):95-100. doi: 10.1161/01.atv.21.1.95.
6
Comparison of I- and In-labeled peptide probes for in vivo detection of oxidized low-density lipoprotein in atherosclerotic plaques.用于体内检测动脉粥样硬化斑块中氧化型低密度脂蛋白的碘标记和铟标记肽探针的比较。
Ann Nucl Med. 2018 Jul;32(6):425-429. doi: 10.1007/s12149-018-1255-y. Epub 2018 Apr 12.
7
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
Circulation. 1999 Mar 9;99(9):1222-9. doi: 10.1161/01.cir.99.9.1222.
8
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.在血脂异常的肥胖小鼠中,低密度脂蛋白氧化增加和高密度脂蛋白抗氧化防御受损与巨噬细胞归巢增加及动脉粥样硬化相关:卵磷脂胆固醇酰基转移酶基因转移可减轻动脉粥样硬化。
Circulation. 2003 Apr 1;107(12):1640-6. doi: 10.1161/01.CIR.0000056523.08033.9F. Epub 2003 Mar 24.
9
Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.内皮素-1 过表达加剧载脂蛋白 E 基因敲除小鼠的动脉粥样硬化并诱导其发生主动脉瘤。
Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2306-15. doi: 10.1161/ATVBAHA.113.302028. Epub 2013 Jul 25.
10
Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice.抗氧化型低密度脂蛋白自身抗体无法改变载脂蛋白E缺陷小鼠体内注射的氧化型低密度脂蛋白的清除率。
J Lipid Res. 2004 Jul;45(7):1347-54. doi: 10.1194/jlr.M400075-JLR200. Epub 2004 Apr 21.

引用本文的文献

1
Radiolabeling lipoproteins to study and manage disease.放射性标记脂蛋白以研究和管理疾病。
Eur J Nucl Med Mol Imaging. 2025 Apr 28. doi: 10.1007/s00259-025-07281-4.
2
Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.人工高密度脂蛋白纳米颗粒在心血管研究中的应用。
Molecules. 2019 Aug 2;24(15):2829. doi: 10.3390/molecules24152829.
3
In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.多种动脉粥样硬化模型中高密度脂蛋白的体内正电子发射断层显像
JACC Cardiovasc Imaging. 2016 Aug;9(8):950-61. doi: 10.1016/j.jcmg.2016.01.020. Epub 2016 May 25.
4
Lipoproteins and lipoprotein mimetics for imaging and drug delivery.用于成像和药物递送的脂蛋白及脂蛋白模拟物。
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):116-131. doi: 10.1016/j.addr.2016.04.020. Epub 2016 Apr 29.
5
Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 2: Radiolabeled Probes.用于心血管成像和治疗递送的纳米颗粒,第2部分:放射性标记探针。
J Nucl Med. 2015 Nov;56(11):1637-41. doi: 10.2967/jnumed.115.164145. Epub 2015 Aug 20.
6
Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.用于药物靶向和成像的脂蛋白相关及载脂蛋白介导的递送系统。
Curr Med Chem. 2015;22(31):3631-51. doi: 10.2174/0929867322666150716114625.
7
Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level.金纳米晶体标记允许从亚细胞到宏观水平对低密度脂蛋白进行成像。
ACS Nano. 2013 Nov 26;7(11):9761-70. doi: 10.1021/nn403258w. Epub 2013 Oct 17.
8
Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases.用于脂蛋白及相关疾病成像的纳米晶核脂蛋白仿生材料
Curr Cardiovasc Imaging Rep. 2013 Feb 1;6(1):45-54. doi: 10.1007/s12410-012-9181-1.
9
Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents.用半渗透纳米粒子对比剂定量研究晚期动脉粥样硬化中血管屏障破坏的演变。
PLoS One. 2011;6(10):e26385. doi: 10.1371/journal.pone.0026385. Epub 2011 Oct 18.
10
Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.载脂蛋白 A-I 模拟肽可预防糖尿病小鼠动脉粥样硬化的发展并减少斑块炎症。
Diabetes. 2010 Dec;59(12):3223-8. doi: 10.2337/db10-0844. Epub 2010 Sep 8.